InvestorQ : What is India doing about the shortage of Remdesevir in India?
Anjana Aiyar made post

What is India doing about the shortage of Remdesevir in India?

Answer
image
Khushi Patel answered.
8 months ago
Follow

There is a shortage being faced and companies have already taken steps for the same. With Coronavirus infections accelerating rapidly, Cipla decided to double production of its Remdesevir drug to keep pace with the growing demands in the midst of the pandemic. India has already overtaken Brazil and is now only next to the US in terms of total number of afflictions as well as the gravity of the COVID situation.

Remdesevir is an antiviral drug that is generally being administered to COVID patients in India that helps them in the recovery process. Cipla holds the license to make Remdesevir it supplies to over 100 countries. This drug is licensed to Cipla by Gilead Inc. However, WHO has already emphasized that the administration of Remdesevir does not bring about any perceptible improvement in the condition of COVID patients.

3 Views